GENE ONLINE|News &
Opinion
Blog

Tyler Chen

"Never go to a doctor whose office plants have died."- Erma Bombeck

WRITTEN BY Tyler Chen

How CDMOs are Restructuring the Biopharma Landscape – An Interview with Bobby Sheng
2021-12-06
Singapore Will Not Cover Covid-19 Medical Bills for Those Unvaccinated by Choice
2021-11-10
Meiji Seika Pharma to Expand CMO Business with India Manufacturing Site
2021-11-09
WuXi Biologics Launch Its Largest GMP Drug Facility and First Automated Vial Packaging Line
2021-11-03
GC Pharma’s Enzyme Replacement Therapy Wins Orphan Drug Designation from EMA
2021-11-02
Angel Pharma Pushes First-In-Class ITK Inhibitor into Trial in China
2021-10-27
10x Genomics Eyes Regional Opportunities in Asia-Pacific, Launches First Overseas Manufacturing Hub
2021-10-26
Daiichi Sankyo to Launch mRNA COVID-19 Vaccine in 2022, Shionogi Presents Clinical Results of COVID-19 Oral Drug
2021-10-22
Shanghai Startup Poised for $325M IPO on Nasdaq
2021-10-21
WuXi ATU Launches Fourth Manufacturing Site for Gene and Cell Therapy CTDMO Service
2021-10-19
Dr. Reddy Stands as the First Indian Firm to Launch Cancer Drug in Chinese Market
2021-10-15
China’s Metabolic Drugmaker Scores $70M Series C to Accelerate Drug Trials
2021-10-13
Samsung Biologics Inks CDMO Deal with Enzolytics on HIV and COVID-19 Antibodies
2021-10-08
2021 CSCO Highlights: JW Therapeutics, Innovent, Ambrx, HUTCHMED Release Latest Data on Cancer Drugs
2021-10-07
Kyowa Kirin, Amgen’s Atopic Dermatitis Drug Delivers Strong Results in Phase 2 Trial
2021-10-05
1 2 3 9
Scroll to Top